Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2025. Further, the company has informed the Exchange regarding voting results.
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited has filed the Scrutinizer's report and voting results from its Annual General Meeting held on September 30, 2025, with the stock exchange. This is a standard post-AGM compliance disclosure that shows how shareholders voted on the resolutions put forward at the meeting. The filing itself is routine regulatory practice required after every AGM, ensuring transparency on resolutions passed by shareholders.
This is a routine procedural filing and does not signal any major event. Investors should review the voting results for details on how resolutions were passed and any notable dissent from shareholders.